Christine Ring

Chief Legal Officer

Christine Ring (Chief Legal Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Nurix Therapeutics, Inc. (NRIX). The largest single filing was $642K of NRIX (37,600 sh × $17.07, as filed), executed Nov 24 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.8M

shares × price, as filed

Last traded

Sep 2

Filed Sep 2

Median ADV $54.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $3.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

NRIX

Nurix Therapeutics, Inc. NRIX · 0 buys · 16 sells 16 filings

Recent filings

NRIXSALE Nurix Therapeutics, Inc. View filing → $238K
14,261 sh × $16.66
Exec Feb 9
Filed Feb 9 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $642K
37,600 sh × $17.07
Exec Nov 24 2025
Filed Nov 24 2025 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $113K
5,660 sh × $19.94
Exec Jan 31 2025
Filed Feb 3 2025 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $112K
5,760 sh × $19.50
Exec Jan 2 2025
Filed Jan 2 2025 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $125K
5,760 sh × $21.73
Exec Dec 2 2024
Filed Dec 2 2024 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $140K
5,760 sh × $24.28
Exec Nov 1 2024
Filed Nov 1 2024 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $102K
4,182 sh × $24.31
Exec Oct 30 2024
Filed Oct 30 2024 · 5:30 PM ET NRIXSALE Nurix Therapeutics, Inc. View filing → $121K
5,460 sh × $22.19
Exec Oct 1 2024
Filed Oct 1 2024 · 5:30 PM ET